Life-threatening emergency cases in dermatology
Life-threatening emergency cases may be rare, but they can be complex. At EADV this week, experts review cases physicians should be aware of.
EADV report addresses novel treatments for cutaneous lymphoma
Potential new treatment with targeted monoclonal antibodies offers new hope for cutaneous lymphoma patients.
Advent of immunotherapy may require a new, expanded role for dermatologists
With immunotherapy as a key treatment for melanoma, dermatologists should be prepared to treat its cutaneous side effects and refer for adrenal sufficiency, uveitis, thyroid disease and other non-cutaneous side effects.
EADV report highlights the future of checkpoint inhibitors in advanced melanoma
Checkpoint inhibitors have clearly changed the prognosis of melanoma, yet the search for evidence-based answers to these and other questions regarding their use continues, experts report at EADV this week.
2 Clarke Drive Cranbury, NJ 08512